Union Pacific Corporation Stock: Shares Fall 3.91% Following BMO Downgrade
Union Pacific Corporation's stock ended the session on January 7 with a sharp decline, dropping 3.91% to close at $224.48. This downward movement occurred despite a generally favorable stock market environment, with the S&P 500 gaining 0.36% over the same period. The American railroad operator now shows a marked underperformance compared to its benchmark index since the beginning of the year.
Challenging Trading Session for Union Pacific
Union Pacific's stock experienced a tough session on Tuesday, losing 3.91% to settle at $224.48. Trading volumes reached 4.47 million shares, representing 0.75% of the group's market capitalization, reflecting significant selling pressure. This decline is part of a broader negative trend for the stock, which has seen a decrease of 2.96% over the past week. Over the year, the performance remains negative with a loss of 2.63%, in stark contrast to the 18.33% gain of the S&P 500 over the same period. This divergence highlights the specific challenges faced by the railroad sector in a generally well-oriented stock market. The stock's underperformance relative to the broad index reflects ongoing concerns about the growth prospects of the rail freight business.
Downgrade by BMO Capital Markets Adds to Selling Pressure
The selling pressure on the stock is echoed in the downgrade issued by BMO Capital Markets. The Canadian investment bank lowered its rating on Union Pacific from 'outperform' to 'market perform'. The price target was also reduced from $270 to $255, representing a limited upside potential of 9.2% from the last closing price. This revision is based on two main factors identified by analysts: limited visibility on regulatory outcomes and persistent weakness in freight demand. These factors weigh on the earnings expectations for the railroad group. Freight demand is a leading indicator of economic activity, and its slowdown raises questions about the strength of American growth in the coming quarters. However, the consensus among analysts remains constructive, with 17 out of 27 brokerage houses maintaining a buy or higher recommendation, while 10 suggest holding the stock. The median price target is set at $261 according to LSEG data, suggesting potential for recovery despite the challenging context.
